A monoclonal antibody recognising polyoma virus middle T antigen, used to detect and study PyMT expression in polyoma virus and tumour model research.
| Inventor | Institute |
|---|---|
| Stephen Dilworth | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 151186 |
|---|---|
| Product description: | Anti-PyLT [PyMT] is a monoclonal antibody that recognises polyoma virus middle T antigen. It is used to detect and study PyMT expression, supporting research into mouse polyoma virus early antigen biology, viral oncogenesis and polyoma virus-driven tumour models. Reported applications for clone PyMT include immunoprecipitation, ELISA, immunocytochemistry/immunofluorescence and western blot. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2b |
| Molecular weight: | 55 kDa |
| Immunogen: | Polyoma virus-transformed Wistar rat fibroblast cell line Py REWA5/T1A1. |
| Myeloma used: | P3/NS1/1-Ag4.1 |
| Cat. #: | 151186 |
|---|---|
| Provenance and Ownership: | The Anti-PyLT [PyMT] is owned by Cancer Research UK. CancerTools supplies the Anti-PyLT [PyMT] under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-PyLT [PyMT] directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Microbiology |
| Application: | ELISA ; WB ; IHC ; IF ; IP ; WB |
| Target: | Polyoma virus Middle T antigen |
| Reactivity: | Virus |
| Clone: | PyMT |
| Host: | Rat |
| Class: | Monoclonal |
| Target background: | The mouse polyoma virus (Py) is an oncogenic virus, which encodes for three early proteins, large, middle and small T (tumour) antigen. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
DeVette et al. 2020. Oncoimmunology. 9(1):1685300. PMID: 32002300. Kim et al. 2016. Cancer Res. 76(21):6424-6435. PMID: 27569213. Gao et al. 2012. Cancer Res. 72(6):1384-94. PMID: 22282653. Guest et al. 2010. Int J Cancer. 126(10):2308-18. PMID: 19816927. Dilworth et al. 1982. EMBO J. 1(11):1319-28. PMID: 6327264. Dilworth et al. 1982. Proc Natl Acad Sci U S A. 79(4):1059-63. PMID: 6175960. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.